SEC Form 5 · accession 0001140361-16-052406
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Baffi
Officer — EVP, Technical Operations
Period of report
Dec 31, 2015
Accepted (ET)
Feb 12, 2016 · 5:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 9, 2015 | G | 2,500 | $0.00 | D | 97,000 | D | |
| Common Stock | Jun 9, 2015 | G | 2,500 | $0.00 | A | 31,676 | I | Shares held by Baffi Family Trust |
| Common StockF2 | Oct 31, 2015 | A | 26 | $51.2635 | A | 97,026 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On June 9, 2015 the reporting person gifted 2,500 shares of common stock to his family trust. The reporting person is the trustee.
- F2Represents shares acquired by the reporting person on October 31, 2015 pursuant to the issuer's Employee Stock Purchase Plan.